Dr. John de Groot, MD Anderson Cancer Center

“Since I started my training, there was the establishment of what’s currently the standard of care. Which is the concurrent use of radiation and temozolomide and adjuvant temozolomide. That, unfortunately, has not changed though, in the last 15 years. So although I got to see the transformation of the field and maybe for the first time, a large number of patients who have five years and beyond survival, we still have not been able to really make that a reality for a majority of patients. So we’ve unfortunately had some limitations in the advancements since that time.”

Along with Brains for the Cure, the Head for the Cure Foundation aims to change the future of treatment for brain tumor patients. Interested in learning more? Email [email protected].